Cornea/External Disease News

NASHVILLE, Tenn. — A preservative-free brimonidine tartrate ophthalmic solution was statistically noninferior to Bausch + Lomb’s Lumify, offering an alternative option for ocular redness relief, according to a poster at Optometry’s Meeting.

NASHVILLE, Tenn. — Patients with keratoconus may need a variety of contact lenses after surgery, making it critical for clinicians to have multiple options in their toolbox, according to a speaker at Optometry’s Meeting.

The FDA granted breakthrough therapy and regenerative medicine advanced therapy designations for AURN001 for the treatment of corneal edema secondary to corneal endothelial disease, according to a press release from Aurion Biotech.

In addition to accidental ocular injury associated with e-cigarettes, chronic users may experience reduced tear film quality and stability, potentially increasing the risk for dry eye disease, according to a systematic review.

Obstructive sleep apnea appears to increase the risk for ptosis repair failure and revision surgery, according to a study in Ophthalmic Plastic and Reconstructive Surgery.

KIAWAH ISLAND, S.C. — A study suggested that electrocardiogram screening should be performed in patients with sarcoidosis-associated uveitis because life-threatening cardiac involvement may be present even without symptoms.

Improvements in multiple sign efficacy endpoints were reported for licaminlimab in patients with dry eye disease, with more pronounced effects in patients with a TNFR1 genetic biomarker, according to an Oculis press release.

The neutrophil-to-lymphocyte ratio appeared to distinguish between acute orbital infectious disease and noninfectious inflammation and may aid in clinical intervention, according to a study in Ophthalmic Plastic and Reconstructive Surgery.

Catch up on the top five items in dry eye disease from May.

Some individual meibomian gland metrics may structurally change over a period of hours or days, according to research published in Ophthalmic and Physiological Optics.